Gapping up
In reaction to strong earnings/guidance:
- SCS +6.9%, GIS +2.5%, CTAS +1.1%
M&A news:
- MCHX +8.7% (acquires Sonar Technologies for $12.5 mln in cash and stock with potential for additional $1.5 mln)
Other news:
- SLDB +45.4% (provides data update from sgt-001 development program; demonstrated expression of SGT-001 microdystrophin and nNOS function provide evidence that SGT-001 has the potential to provide therapeutic benefit for patients with Duchenne)
- PCG +13.4% (submits comprehensive, multi-party settlement agreement to CPUC Related to 2017 and 2018 wildfires; settlement agreement prohibits company from seeking $1.625 billion in wildfire-related costs from customers)
- COLM +4.9% (to join S&P MidCap 400)
- ZGNX +3.9% (announces The Lancet has published the results of its Phase 3 clinical trial for FINTEPLA)
- UNIT +3.8% (to join S&P SmallCap 600)
- NLTX +1.4% (prices public offering of 8,925,000 shares of its common stock at $8.40/share)
- DVN +1% (announces sale of Barnett Shale for $770 mln; announces new $1 billion share-repurchase program)
Analyst comments:
- SBRA +6.6% (upgraded to Neutral from Sell at Citigroup)
- CRMD +4.7% (initiated with a Buy at B. Riley FBR)
- DDOG +1.8% (initiated with a Buy at Rosenblatt)
- WMS +1.5% (upgraded to Overweight from Equal Weight at Barclays )
- CCMP +1.5% (upgraded to Buy from Hold at Loop Capital)
- DAL +1.5% (upgraded to Buy from Hold at Deutsche Bank)
- REAL +0.9% (initiated with a Buy at B. Riley FBR)